EP1305409B1
(fr)
|
2000-06-16 |
2009-03-11 |
Biogen Idec MA Inc. |
Elements de regulation renale et leurs procedes d'utilisation
|
US20060035237A1
(en)
|
2002-08-26 |
2006-02-16 |
Markowitz Sanford D |
Methods and compositions for categorizing patients
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
JP4527394B2
(ja)
|
2001-06-01 |
2010-08-18 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
Kim−1の分断を阻害するための分子および方法
|
WO2003027276A2
(fr)
*
|
2001-09-24 |
2003-04-03 |
University Of Aarhus |
Nouvelles compositions et procedes relatifs aux lymphomes et aux leucemies
|
US20050123925A1
(en)
|
2002-11-15 |
2005-06-09 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
DE60220621T2
(de)
|
2001-11-09 |
2008-03-06 |
Proteologics, Inc. |
Posh Nukleinsäure, Polypeptide und darauf bezogene Verfahren
|
AU2003228336B2
(en)
*
|
2002-03-19 |
2009-07-30 |
Curagen Corporation |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
AU2003222965A1
(en)
*
|
2002-04-05 |
2003-10-27 |
University Court Of The University Of Edinburgh |
Schizophrenia associated genes
|
US20050276812A1
(en)
|
2004-06-01 |
2005-12-15 |
Genentech, Inc. |
Antibody-drug conjugates and methods
|
AU2003278137A1
(en)
|
2002-06-20 |
2004-01-06 |
Bristol-Myers Squibb Company |
Identification and regulation of a g-protein coupled receptor, rai-3
|
GB0215224D0
(en)
*
|
2002-07-01 |
2002-08-14 |
Inpharmatica Ltd |
Protein
|
AU2003294250A1
(en)
*
|
2002-11-12 |
2004-06-03 |
Wyeth |
A novel pth responsive gene
|
SI1585546T1
(sl)
|
2002-12-30 |
2008-12-31 |
Biogen Idec Inc |
KIM-1 antagonisti in uporaba za moduliranje imunskega sistema
|
JP4462964B2
(ja)
*
|
2003-03-10 |
2010-05-12 |
第一三共株式会社 |
癌特異的抗原を標的とした抗体
|
WO2004090097A2
(fr)
|
2003-04-03 |
2004-10-21 |
Bristol-Myers Squibb Company |
Polynucleotide codant un nouveau variant d'epissage p2x7 humain appele hbmyp2x7v
|
EP1923401A3
(fr)
*
|
2003-04-14 |
2008-08-20 |
Novartis AG |
Expression génétique associée avec la différenciation des ostéoblastes
|
WO2004099782A2
(fr)
*
|
2003-05-05 |
2004-11-18 |
Bayer Healthcare Ag |
Approche diagnostique et therapeutique des maladies associees au recepteur gpr39 (gpr39) couple a une proteine g
|
WO2005001049A2
(fr)
*
|
2003-06-06 |
2005-01-06 |
Diadexus, Inc. |
Compositions, variants d'epissage et procedes associes a des genes et proteines ovariens specifiques
|
US7294704B2
(en)
|
2003-08-15 |
2007-11-13 |
Diadexus, Inc. |
Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
|
SG195524A1
(en)
|
2003-11-06 |
2013-12-30 |
Seattle Genetics Inc |
Monomethylvaline compounds capable of conjugation to ligands
|
US20050153352A1
(en)
*
|
2004-01-09 |
2005-07-14 |
Stanley Chang |
Cancer specific gene MG20
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
GB0404209D0
(en)
*
|
2004-02-25 |
2004-03-31 |
Uws Ventures Ltd |
Materials and methods for treatment of allergic disease
|
DE602005019694D1
(de)
*
|
2004-02-27 |
2010-04-15 |
Inst Curie |
Neue proliferationsmarker in der klinischen praxis und deren verwendung zur krebsprognose oder -diagnose
|
US8124730B1
(en)
|
2004-04-02 |
2012-02-28 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel human P2X7 splice variant, HBMYP2X7v
|
ATE486962T1
(de)
|
2004-04-27 |
2010-11-15 |
Takeda Pharmaceutical |
Neuer ligand eines g-protein-konjugierten rezeptorproteins und verwendung davon
|
US20080166357A1
(en)
*
|
2004-05-11 |
2008-07-10 |
Stefan Golz |
Diagnostics and Therapeutics for Diseases Associated with Dipeptidyl-Peptidase 6 (Dpp6)
|
US8604185B2
(en)
|
2004-07-20 |
2013-12-10 |
Genentech, Inc. |
Inhibitors of angiopoietin-like 4 protein, combinations, and their use
|
AU2005269716B2
(en)
|
2004-07-20 |
2011-01-27 |
Genentech, Inc. |
Inhibitors of angiopoietin-like 4 protein, combinations, and their use
|
JP5318412B2
(ja)
|
2004-07-20 |
2013-10-16 |
ジェネンテック, インコーポレイテッド |
アンジオポエチン様4タンパク質を使用する組成物および方法
|
AU2005286607B2
(en)
|
2004-09-23 |
2011-01-27 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
CN103751780A
(zh)
|
2005-03-02 |
2014-04-30 |
比奥根艾迪克Ma公司 |
用于治疗th2介导的疾病的kim-1抗体
|
US20090054321A1
(en)
*
|
2005-04-18 |
2009-02-26 |
O'neill Luke Anthony John |
Polypeptides and use thereof
|
US7799519B2
(en)
*
|
2005-07-07 |
2010-09-21 |
Vanderbilt University |
Diagnosing and grading gliomas using a proteomics approach
|
AU2006320654A1
(en)
*
|
2005-11-29 |
2007-06-07 |
Yupo Ma |
Targeting of SALL4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS)
|
WO2007067730A2
(fr)
|
2005-12-08 |
2007-06-14 |
Medarex, Inc. |
Anticorps monoclonaux humains contre la proteine tyrosine kinase 7 (ptk7) et procedes pour utiliser des anticorps anti-ptk7
|
ES2582652T3
(es)
|
2006-02-10 |
2016-09-14 |
Genentech, Inc. |
Anticuerpos anti-FGF19 y métodos de uso de los mismos
|
ES2544957T3
(es)
|
2006-03-21 |
2015-09-07 |
Genentech, Inc. |
Terapia combinada que implica antagonistas alfa5beta1
|
WO2008054534A2
(fr)
|
2006-05-11 |
2008-05-08 |
Quark Pharmaceuticals, Inc. |
Systèmes de criblage utilisant le rtp801
|
EP2026843A4
(fr)
|
2006-06-09 |
2011-06-22 |
Quark Pharmaceuticals Inc |
Utilisations thérapeutiques d'inhibiteurs de rtp801l
|
US7851144B2
(en)
|
2006-08-18 |
2010-12-14 |
The University Of Washington |
Compositions and methods for detecting cancer
|
GB0620695D0
(en)
*
|
2006-10-18 |
2006-11-29 |
Opsona Therapeutics |
Composition and methods for the treatment of nurdegenerative disease
|
GB0620705D0
(en)
|
2006-10-18 |
2006-11-29 |
Opsona Therapeutics |
Compounds for the modulation of toll-like receptor activity and assay methods for the identification of said compounds
|
EP1932854A1
(fr)
*
|
2006-12-15 |
2008-06-18 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Polypeptides s'apparentant à une protéine de membrane associée à un lysosome (LAMP), ligands correspondants et leur utilisation dans le cadre de la détection et de la purification de cellules dendritiques plasmacytoïdes humaines
|
EP2377952A1
(fr)
*
|
2007-04-26 |
2011-10-19 |
Ludwig Institute For Cancer Research |
Procédés pour le diagnostic et le traitement d'astrocytomes
|
DK2567707T3
(en)
*
|
2007-07-27 |
2017-07-31 |
Immatics Biotechnologies Gmbh |
Composition of tumour-associated peptides and related anti-cancer vaccine
|
WO2009035786A1
(fr)
|
2007-08-03 |
2009-03-19 |
Genentech, Inc. |
Antagonistes humanisés anti-fgf19 et procédés d'utilisation associés
|
CA2736170A1
(fr)
|
2007-09-06 |
2009-03-12 |
Case Western Reserve University |
Procedes de diagnostic et de traitement de cancers
|
AR066170A1
(es)
|
2007-09-26 |
2009-07-29 |
Genentech Inc |
Anti integrina alfa 5 beta 1
|
US8614311B2
(en)
|
2007-12-12 |
2013-12-24 |
Quark Pharmaceuticals, Inc. |
RTP801L siRNA compounds and methods of use thereof
|
EP2313435A4
(fr)
|
2008-07-01 |
2012-08-08 |
Aveo Pharmaceuticals Inc |
Protéines se liant au récepteur 3 du facteur de croissance des fibroblastes (fgfr3)
|
AR072804A1
(es)
|
2008-07-15 |
2010-09-22 |
Genentech Inc |
Conjugados derivados de antraciclina,proceso para su preparacion,composiciones farmaceuticas que los contienen y su uso como agentes antitumorales.
|
ES2445892T3
(es)
*
|
2008-08-25 |
2014-03-05 |
Janssen Biotech, Inc. |
Biomarcadores para el tratamiento anti-TNF en colitis ulcerosa y trastornos relacionados
|
US9260499B2
(en)
|
2008-10-20 |
2016-02-16 |
Sapporo Medical University |
Tumor antigen peptide and use thereof
|
AU2014201027B2
(en)
*
|
2008-12-08 |
2015-11-19 |
Compugen Ltd. |
FAM26F polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
EP2373690B1
(fr)
|
2008-12-08 |
2015-02-11 |
Compugen Ltd. |
Anticorps spécifiques du tmem154
|
JP6051048B2
(ja)
|
2009-03-25 |
2016-12-21 |
ジェネンテック, インコーポレイテッド |
新規な抗α5β1抗体及びその使用
|
US8470980B2
(en)
|
2009-09-09 |
2013-06-25 |
Centrose, Llc |
Extracellular targeted drug conjugates
|
HRP20211444T1
(hr)
|
2010-01-29 |
2021-12-24 |
Chugai Seiyaku Kabushiki Kaisha |
Anti-dll3 antitijelo
|
JP5988436B2
(ja)
|
2010-02-23 |
2016-09-07 |
ジェネンテック, インコーポレイテッド |
腫瘍の診断と治療のための組成物と方法
|
DK2528625T3
(da)
|
2010-04-15 |
2013-10-14 |
Spirogen Sarl |
Pyrrolobenzodiazepiner og konjugater deraf
|
CN114246952A
(zh)
|
2010-06-08 |
2022-03-29 |
基因泰克公司 |
半胱氨酸改造的抗体和偶联物
|
US20120121615A1
(en)
|
2010-11-17 |
2012-05-17 |
Flygare John A |
Alaninyl maytansinol antibody conjugates
|
ES2567276T3
(es)
|
2011-05-12 |
2016-04-21 |
Genentech, Inc. |
Método de LC-MS/MS de monitoreo de múltiples reacciones para detectar anticuerpos terapéuticos en muestras de animales usando péptidos de cambio de marco
|
CN103987407B
(zh)
|
2011-10-14 |
2016-08-24 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓及其偶联物
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
PL2814844T3
(pl)
|
2012-02-15 |
2017-12-29 |
Novo Nordisk A/S |
Przeciwciała wiążące i blokujące receptor aktywujący wykazujący ekspresję na komórkach szpikowych -1 (trem-1)
|
EP2814842B1
(fr)
|
2012-02-15 |
2018-08-22 |
Novo Nordisk A/S |
Anticorps liant peptidoglycane reconnaissance protéine 1
|
WO2013130093A1
(fr)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Biomarqueurs pour un traitement à base de composés chimiothérapeutiques anti-tubuline
|
JP2015528818A
(ja)
|
2012-08-02 |
2015-10-01 |
ジェネンテック, インコーポレイテッド |
抗etbr抗体およびイムノコンジュゲート
|
JP2015529656A
(ja)
|
2012-08-02 |
2015-10-08 |
ジェネンテック, インコーポレイテッド |
抗etbr抗体および免疫複合体
|
ES2660029T3
(es)
|
2012-10-12 |
2018-03-20 |
Medimmune Limited |
Conjugados de anticuerpo-pirrolobenzodiazepinas
|
CA2885340C
(fr)
|
2012-10-12 |
2016-11-08 |
Spirogen Sarl |
Pyrrolobenzodiazepines et leurs conjugues
|
ES2680153T3
(es)
|
2012-10-12 |
2018-09-04 |
Adc Therapeutics Sa |
Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas
|
MX364327B
(es)
|
2012-10-12 |
2019-04-23 |
Medimmune Ltd |
Conjugados del anticuerpo pirrolobenzodiazepina - anti-cd22.
|
JP6392763B2
(ja)
|
2012-10-12 |
2018-09-19 |
エイディーシー・セラピューティクス・エス・アーAdc Therapeutics Sa |
ピロロベンゾジアゼピン−抗体結合体
|
HUE039329T2
(hu)
|
2012-10-12 |
2018-12-28 |
Adc Therapeutics Sa |
Pirrolobenzodiazepin-antitest konjugátumok
|
RS57694B1
(sr)
|
2012-10-12 |
2018-11-30 |
Adc Therapeutics Sa |
Pirolobenzodiazepin - anti-psma konjugati antitela
|
ES2658888T5
(es)
|
2012-12-21 |
2021-10-19 |
Medimmune Ltd |
Pirrolobenzodiazepinas y conjugados de las mismas
|
WO2014096365A1
(fr)
|
2012-12-21 |
2014-06-26 |
Spirogen Sàrl |
Dimères de pyrrolobenzodiazépines asymétriques à utiliser dans le traitement de maladies prolifératives et auto-immunes
|
JP6340019B2
(ja)
|
2013-03-13 |
2018-06-06 |
メドイミューン・リミテッドMedImmune Limited |
ピロロベンゾジアゼピン及びそのコンジュゲート
|
AU2014230735B2
(en)
|
2013-03-13 |
2018-03-15 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
NZ710745A
(en)
|
2013-03-13 |
2019-03-29 |
Genentech Inc |
Pyrrolobenzodiazepines and conjugates thereof
|
SI2970473T1
(sl)
|
2013-03-14 |
2017-10-30 |
Bristol-Myers Squibb Company |
Kombinacija dr5 agonista in anti-pd-1 antagonista in postopek uporabe
|
EA201690195A1
(ru)
|
2013-08-12 |
2016-05-31 |
Дженентек, Инк. |
Конъюгатные соединения антитело-лекарство на основе димера 1-(хлорметил)-2,3-дигидро-1h-бензо[e]индола и способы применения и лечения
|
WO2015052532A1
(fr)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Conjugués anticorps-pyrrolobenzodiazépines
|
US9956299B2
(en)
|
2013-10-11 |
2018-05-01 |
Medimmune Limited |
Pyrrolobenzodiazepine—antibody conjugates
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
US9950078B2
(en)
|
2013-10-11 |
2018-04-24 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
MX371092B
(es)
|
2013-12-16 |
2020-01-16 |
Genentech Inc |
Compuestos peptidomimeticos y conjugados de anticuerpo-farmaco de los mismos.
|
JP6980384B2
(ja)
|
2013-12-16 |
2021-12-15 |
ジェネンテック, インコーポレイテッド |
1−(クロロメチル)−2,3−ジヒドロ−1h−ベンゾ[e]インドール二量体抗体−薬物コンジュゲート化合物、並びに使用及び処置の方法
|
PE20161394A1
(es)
|
2013-12-16 |
2017-01-06 |
Genentech Inc |
Compuestos peptidomimeticos y sus conjugados de anticuerpo-farmaco
|
RS65136B1
(sr)
|
2014-07-17 |
2024-02-29 |
Novo Nordisk As |
Mutageza usmerena na lokaciju trem-1 antitela za smanjenje viskoziteta
|
US10188746B2
(en)
|
2014-09-10 |
2019-01-29 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
EP3191134B1
(fr)
|
2014-09-12 |
2019-11-20 |
Genentech, Inc. |
Intermédiaires disulfure d'anthracycline, conjugué anticorps-médicaments et procédés
|
BR112017003236A2
(pt)
|
2014-09-12 |
2017-11-28 |
Genentech Inc |
anticorpos elaborados com cisteína, conjugados de droga e anticorpos, método de preparação de conjugado de droga e anticorpo e composição farmacêutica
|
CR20170099A
(es)
|
2014-09-17 |
2017-07-19 |
Genentech Inc |
Pirrolobenzodiazepinas y conjugados de anticuerpos-disulfuro de las mismas
|
MX2017006770A
(es)
|
2014-11-25 |
2018-02-09 |
Adc Therapeutics Sa |
Conjugados de pirrolobenzodiazepina y anticuerpo.
|
EP3226909A1
(fr)
|
2014-12-03 |
2017-10-11 |
Genentech, Inc. |
Composés d'amine quaternaire et conjugués anticorps-médicament de ceux-ci
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
MA43345A
(fr)
|
2015-10-02 |
2018-08-08 |
Hoffmann La Roche |
Conjugués anticorps-médicaments de pyrrolobenzodiazépine et méthodes d'utilisation
|
MA43354A
(fr)
|
2015-10-16 |
2018-08-22 |
Genentech Inc |
Conjugués médicamenteux à pont disulfure encombré
|
MA45326A
(fr)
|
2015-10-20 |
2018-08-29 |
Genentech Inc |
Conjugués calichéamicine-anticorps-médicament et procédés d'utilisation
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
US20170315132A1
(en)
|
2016-03-25 |
2017-11-02 |
Genentech, Inc. |
Multiplexed total antibody and antibody-conjugated drug quantification assay
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
JP2019522633A
(ja)
|
2016-05-20 |
2019-08-15 |
ジェネンテック, インコーポレイテッド |
Protac抗体コンジュゲート及び使用方法
|
CN109313200B
(zh)
|
2016-05-27 |
2022-10-04 |
豪夫迈·罗氏有限公司 |
用于表征位点特异性抗体-药物缀合物的生物分析性方法
|
WO2017214024A1
(fr)
|
2016-06-06 |
2017-12-14 |
Genentech, Inc. |
Médicaments conjugués d'anticorps silvestrol et procédés d'utilisation
|
WO2018031662A1
(fr)
|
2016-08-11 |
2018-02-15 |
Genentech, Inc. |
Promédicaments de pyrrolobenzodiazépine et conjugués d'anticorps de ceux-ci
|
WO2018065501A1
(fr)
|
2016-10-05 |
2018-04-12 |
F. Hoffmann-La Roche Ag |
Procédés de préparation de conjugués anticorps-médicament
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
PT3544636T
(pt)
|
2017-02-08 |
2021-05-04 |
Medimmune Ltd |
Conjugados de anticorpos-pirrolobenzodiazepinas
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
WO2018192944A1
(fr)
|
2017-04-18 |
2018-10-25 |
Medimmune Limited |
Conjugués de pyrrolobenzodiazépine
|
KR20190141666A
(ko)
|
2017-04-20 |
2019-12-24 |
에이디씨 테라퓨틱스 에스에이 |
항-axl 항체-약물 접합체로의 병용 요법
|
AU2018285562B2
(en)
|
2017-06-14 |
2024-01-18 |
Adc Therapeutics Sa |
Dosage regimes for the administration of an anti-CD19 ADC
|
ES2906965T3
(es)
|
2017-08-18 |
2022-04-21 |
Medimmune Ltd |
Conjugados de pirrolobenzodiazepina
|
WO2019060398A1
(fr)
|
2017-09-20 |
2019-03-28 |
Ph Pharma Co., Ltd. |
Analogues de thailanstatine
|
EP3732195A4
(fr)
|
2017-12-28 |
2022-02-09 |
Chugai Seiyaku Kabushiki Kaisha |
Agent thérapeutique induisant une cytotoxicité
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
TWI790370B
(zh)
|
2018-04-02 |
2023-01-21 |
美商必治妥美雅史谷比公司 |
抗trem-1抗體及其用途
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
GB201814281D0
(en)
|
2018-09-03 |
2018-10-17 |
Femtogenix Ltd |
Cytotoxic agents
|
TW202037381A
(zh)
|
2018-10-24 |
2020-10-16 |
瑞士商赫孚孟拉羅股份公司 |
綴合化學降解誘導劑及使用方法
|
WO2020123275A1
(fr)
|
2018-12-10 |
2020-06-18 |
Genentech, Inc. |
Peptides de photoréticulation pour conjugaison spécifique de site à des protéines contenant fc
|
GB201901197D0
(en)
|
2019-01-29 |
2019-03-20 |
Femtogenix Ltd |
G-A Crosslinking cytotoxic agents
|
TWI799824B
(zh)
|
2020-03-31 |
2023-04-21 |
日商中外製藥股份有限公司 |
Dll3靶向之多特異性抗原結合分子及其用途
|
GB2597532A
(en)
|
2020-07-28 |
2022-02-02 |
Femtogenix Ltd |
Cytotoxic compounds
|
CN114113603B
(zh)
*
|
2021-06-30 |
2023-11-17 |
四川大学华西医院 |
Cytl1作为胃癌预后标志物的应用
|